Lynn Malec

636 total citations
43 papers, 294 citations indexed

About

Lynn Malec is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Lynn Malec has authored 43 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Lynn Malec's work include Hemophilia Treatment and Research (34 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Lynn Malec is often cited by papers focused on Hemophilia Treatment and Research (34 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Lynn Malec collaborates with scholars based in United States, Canada and United Kingdom. Lynn Malec's co-authors include Margaret V. Ragni, Robert F. Sidonio, Guy Young, Stacy E. Croteau, James Cooper, Peter A. Kouides, Davide Matino, Michael U. Callaghan, Barbara A. Gaines and Christine M. Leeper and has published in prestigious journals such as Blood, Journal of Pediatric Gastroenterology and Nutrition and Thrombosis Research.

In The Last Decade

Lynn Malec

36 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Malec United States 10 248 45 45 29 26 43 294
Llorenç Font Spain 7 60 0.2× 38 0.8× 66 1.5× 48 1.7× 13 0.5× 10 145
Mauro Molteni Italy 7 100 0.4× 81 1.8× 93 2.1× 132 4.6× 12 0.5× 16 269
Alice Trinchero Germany 7 72 0.3× 37 0.8× 121 2.7× 83 2.9× 36 1.4× 22 196
Nihal Bakeer United States 7 190 0.8× 132 2.9× 47 1.0× 58 2.0× 17 0.7× 15 256
Sonata Šaulytė Trakymienė Lithuania 8 178 0.7× 45 1.0× 85 1.9× 12 0.4× 7 0.3× 25 298
P. Harms Germany 5 165 0.7× 38 0.8× 22 0.5× 10 0.3× 15 0.6× 6 254
Jordi Bellart Spain 11 139 0.6× 16 0.4× 35 0.8× 32 1.1× 38 1.5× 23 341
Louise Simcox United Kingdom 9 107 0.4× 14 0.3× 67 1.5× 63 2.2× 8 0.3× 13 290
Sara Biere‐Rafi Netherlands 7 181 0.7× 59 1.3× 118 2.6× 112 3.9× 79 3.0× 12 323
Marta Milan Italy 10 173 0.7× 40 0.9× 187 4.2× 124 4.3× 86 3.3× 28 338

Countries citing papers authored by Lynn Malec

Since Specialization
Citations

This map shows the geographic impact of Lynn Malec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Malec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Malec more than expected).

Fields of papers citing papers by Lynn Malec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Malec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Malec. The network helps show where Lynn Malec may publish in the future.

Co-authorship network of co-authors of Lynn Malec

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Malec. A scholar is included among the top collaborators of Lynn Malec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Malec. Lynn Malec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klamroth, Robert, Annette von Drygalski, Cédric Hermans, et al.. (2025). Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND‐1 and XTEND‐Kids Studies. Haemophilia. 31(3). 391–400.
2.
Drygalski, Annette von, Aric Parnes, Evan C. Chen, et al.. (2024). Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort. Blood Advances. 8(22). 5896–5905. 1 indexed citations
3.
4.
Malec, Lynn, et al.. (2024). Unmet Needs in People with Hemophilia Receiving Prophylaxis Treatment: A Real-World Survey. Blood. 144(Supplement 1). 2314–2314.
5.
Weyand, Angela C., Lynn Malec, & Steven W. Pipe. (2024). Advancements in haemophilia A and health equity: is it time to redefine severity?. The Lancet Haematology. 11(2). e90–e92. 3 indexed citations
6.
7.
Malec, Lynn, An Van Damme, Anthony K.C. Chan, et al.. (2023). Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study. Blood. 141(16). 1982–1989. 9 indexed citations
8.
Malec, Lynn, Amy L. Dunn, Manuel Carção, et al.. (2023). Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children with Severe Hemophilia A in the XTEND-Kids Phase 3 Study. Blood. 142(Supplement 1). 3993–3993.
9.
Malec, Lynn, Flora Peyvandi, Anthony K.C. Chan, et al.. (2023). LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A. Research and Practice in Thrombosis and Haemostasis. 7. 100288–100288. 3 indexed citations
10.
Olasupo, Omotola O, Charles Nakar, Davide Matino, et al.. (2023). Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study. Research and Practice in Thrombosis and Haemostasis. 7(7). 102228–102228. 2 indexed citations
11.
12.
Sidonio, Robert F. & Lynn Malec. (2021). Hemophilia B (Factor IX Deficiency). Hematology/Oncology Clinics of North America. 35(6). 1143–1155. 11 indexed citations
13.
Roberts, Jonathan, et al.. (2021). Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database. Haemophilia. 28(1). 97–108. 7 indexed citations
14.
Malec, Lynn, Dunlei Cheng, Char Witmer, et al.. (2020). The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States. American Journal of Hematology. 95(8). 960–965. 22 indexed citations
15.
Malec, Lynn, Stacy E. Croteau, Michael U. Callaghan, et al.. (2019). Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers. Blood. 134(Supplement_1). 2407–2407. 6 indexed citations
16.
Malec, Lynn. (2019). Nonimmune Anemias. Clinics in Perinatology. 47(1). 143–153. 2 indexed citations
17.
Ragni, Margaret V., et al.. (2017). Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors. Blood. 130. 3689–3689. 1 indexed citations
18.
Ragni, Margaret V., Allison James, Craig D. Seaman, et al.. (2017). Feasibility of the Von Willebrand disease PREVENT trial. Thrombosis Research. 156. 8–13. 8 indexed citations
19.
Ragni, Margaret V. & Lynn Malec. (2014). Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance. Expert Review of Hematology. 7(6). 747–755. 15 indexed citations
20.
Malec, Lynn, Robert F. Sidonio, Kenneth J. Smith, & James Cooper. (2014). Three Cost-utility Analyses of Screening for Intracranial Hemorrhage in Neonates With Hemophilia. Journal of Pediatric Hematology/Oncology. 36(6). 474–479. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Llorenç Font Breakdown of academic impact, for papers by Mauro Molteni Breakdown of academic impact, for papers by Alice Trinchero Breakdown of academic impact, for papers by Nihal Bakeer Breakdown of academic impact, for papers by Sonata Šaulytė Trakymienė Breakdown of academic impact, for papers by P. Harms Breakdown of academic impact, for papers by Jordi Bellart Breakdown of academic impact, for papers by Louise Simcox Breakdown of academic impact, for papers by Sara Biere‐Rafi Breakdown of academic impact, for papers by Marta Milan
Rankless by CCL
2026